Fortress Biotech (FBIO) Depreciation & Amortization (IS) (2016 - 2018)
Fortress Biotech has reported Depreciation & Amortization (IS) over the past 3 years, most recently at $871000.0 for Q3 2018.
- Quarterly results put Depreciation & Amortization (IS) at $871000.0 for Q3 2018, up 71.79% from a year ago — trailing twelve months through Sep 2018 was $3.2 million (up 53.69% YoY), and the annual figure for FY2017 was $2.1 million, up 283.3%.
- Depreciation & Amortization (IS) for Q3 2018 was $871000.0 at Fortress Biotech, up from $857000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (IS) for FBIO hit a ceiling of $871000.0 in Q3 2018 and a floor of $500000.0 in Q2 2017.
- Median Depreciation & Amortization (IS) over the past 3 years was $560500.0 (2016), compared with a mean of $652625.0.
- Biggest five-year swings in Depreciation & Amortization (IS): rose 5.69% in 2017 and later soared 71.79% in 2018.
- Fortress Biotech's Depreciation & Amortization (IS) stood at $545000.0 in 2016, then grew by 5.69% to $576000.0 in 2017, then soared by 51.22% to $871000.0 in 2018.
- The last three reported values for Depreciation & Amortization (IS) were $871000.0 (Q3 2018), $857000.0 (Q2 2018), and $859000.0 (Q1 2018) per Business Quant data.